Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities FOLD - Amicus Therapeutics, Inc.
61.7 M
LAST VALUE
-46.07%
2 YEAR CAGR
-32.82%
5 YEAR CAGR
7.70%
10 YEAR CAGR